No­var­tis is lat­est vic­tim of cy­ber­at­tack, but claims no con­fi­den­tial da­ta com­pro­mised — re­port

Just a few months ago, cy­ber­se­cu­ri­ty ex­perts told End­points News that the bio­phar­ma in­dus­try is large­ly un­pre­pared for cy­ber­at­tacks. No­var­tis is the lat­est com­pa­ny to …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER